Palantir NHS contract opponents brought their campaign to hospital gates on Thursday 1 October 2026. Doctors, patient groups and human rights campaigners planned protests outside about 30 hospitals and Palantir’s London headquarters, a day after the Guardian reported that more than 44,000 people had filed legal objections to the company’s software handling their health records. Their demand is simple: use the break clause and do not renew the deal beyond its first term in early 2027.
The £330 million Palantir NHS contract pays the US data company to run the Federated Data Platform (FDP), software that joins up information from hospitals so they can manage waiting lists, theatre time and discharges. Ministers are reviewing it and are expected to decide by December. The new prime minister, Andy Burnham, who took office in July, has not commented in public.
This article explains what the contract covers, why the fears have grown so fast in 2026, what Palantir and the government say in its defence, what the break clause allows, and what the row means for patients and for any UK organisation buying critical software from an overseas supplier.
Table of contents
- What the Palantir NHS Contract Covers
- Why Fears Over the Palantir NHS Contract Grew in 2026
- The Five Fears Behind the Palantir NHS Contract Row
- The Case for Keeping the Palantir NHS Contract
- What the Break Clause in the Palantir NHS Contract Allows
- Palantir’s Wider Footprint in Britain
- What the Palantir NHS Contract Means for Patients
- Lessons From the Palantir NHS Contract for UK Buyers
- Palantir NHS Contract FAQ
- References and Further Reading
What the Palantir NHS Contract Covers
NHS England awarded the Federated Data Platform contract in November 2023 to a consortium led by Palantir, with Accenture, PwC, NECS (an NHS-owned support unit) and the consultancy Carnall Farrar. The platform runs on Palantir’s Foundry software and connects data held in separate hospital systems, so a trust can see its whole patient flow in one place.
How it began
The Palantir NHS contract grew out of pandemic work. The Register reports that Palantir won about £60 million of contracts for similar work during Covid-19, starting with an award of just £1 in 2020. Critics have also asked about a 2019 meeting between Boris Johnson, Dominic Cummings and Peter Thiel, for which, Wrigley told MPs, there are no minutes. Those early, low-cost contracts are why opponents argue the company was already embedded before the Palantir NHS contract was ever competed.
The money
The headline value of the Palantir NHS contract is £330 million over seven years, worth about $440 million. The procurement data service Stotles lists the published award to Palantir Technologies UK at £182.2 million, with the larger figure being the maximum envelope as more trusts join. Surrounding contracts add more: Stotles lists a £24.9 million Foundry transition and exit contract, an £11.5 million data platform services extension and a £23.5 million data management platform services contract.
Published figures around the platform, £ million (our arithmetic: the three surrounding contracts total £59.9m)
The term and the break point
Stotles describes a 3+2+1+1 structure: an initial three-year term followed by three optional extensions, seven years in all. The government does not need to cancel anything to end it. If ministers do not trigger the first extension, the contract ends with the first term. Reports place that point in February or March 2027, which is why the review has to finish by the end of this year.
The safeguards the NHS cites
The NHS says patient data stays in Britain, belongs to the health service rather than the supplier, and is not used for commercial purposes or to train AI. NHS England told the Guardian: “All NHS organisations remain in control of their data within the FDP, with suppliers unable to access it for their own purposes.”
| Term | Detail |
|---|---|
| Buyer | NHS England, with the Department of Health and Social Care deciding on renewal |
| Awarded | November 2023 |
| Supplier group | Palantir with Accenture, PwC, NECS and Carnall Farrar |
| Value | Up to £330m over seven years; £182.2m published award to Palantir |
| Structure | Three years, then optional extensions of two, one and one years |
| First break point | February or March 2027 |
| Decision due | By December 2026 |
Why Fears Over the Palantir NHS Contract Grew in 2026
Opposition to the Palantir NHS contract is not new. What changed this year is that it spread from campaign groups to doctors’ leaders, MPs, NHS data professionals and finally ministers.
Doctors and MPs turn against it
In February the British Medical Association chair, Tom Dolphin, told the British Medical Journal: “Given Palantir’s track record, including controversies in the US involving immigration enforcement… we believe there must be a complete break from Palantir technologies in the NHS.” The BMA has advised doctors not to use the platform, citing patient trust, data security and NHS independence.
In April the Liberal Democrat MP Martin Wrigley led a Westminster Hall debate on the Palantir NHS contract. On 3 June the cross-party Science, Innovation and Technology Committee published a 70-page report that called on the government to use the 2027 break clause. “Palantir’s increasing presence across the public sector represents an unacceptable point of weakness,” it said. The Health and Social Care Committee has made the same call.
The public and the party
A YouGov poll published in July found 65% of Britons backed ending the Palantir NHS contract. Petitions organised by 38 Degrees had passed 229,000 signatures by April. In late September, delegates at the Labour Party conference in Liverpool pressed an emergency motion asking the Department of Health and Social Care to use the break clause. Then, on 30 September, came the legal objections.
| Date (2026) | Event |
|---|---|
| February | BMA chair calls for “a complete break” from Palantir in the NHS |
| April | Westminster Hall debate; minister says the break clause will be weighed |
| May | London mayor blocks a £50m Metropolitan Police deal with Palantir |
| 3 June | Science committee report urges the government to use the break clause |
| July | YouGov poll: 65% back ending the deal; Andy Burnham becomes prime minister |
| September | Tom Watson joins Palantir; Labour conference motion; 44,000 objections |
| 1 October | Protests at about 30 hospitals and Palantir’s London office |
| December | Expected ministerial decision |
The Five Fears Behind the Palantir NHS Contract Row
The arguments against the Palantir NHS contract are often run together. Pulled apart, they make five separate claims, and each needs a different answer.
1. Trust and the company’s other customers
Most critics object less to the platform than to Palantir’s other work, for the Israeli military and for US immigration enforcement. “The NHS has to function on trust, the trust I can tell my doctor anything. Those ethical concerns are basically poisoning everything,” Duncan McCann, head of technology and data at the Good Law Project, told AFP. The science committee also noted that Palantir’s co-founder Peter Thiel, a close ally of Donald Trump, has criticised the idea of a national health service.
2. Access to patient data
The committee report cited claims that Palantir had been granted “unlimited access” to identifiable patient information through the platform, and asked the government to explain “on what statutory basis this was authorised, when, and by whom”. The NHS and Palantir both say the company processes data only on the NHS’s instructions and cannot use it for its own purposes.
3. Lock-in and who owns the code
Wrigley’s case in April was about ownership. “The current contract delivers a subscription service that leaves no deliverables after the subscription, no software, no improvements and no intellectual property after spending more than £330 million,” he told MPs, calling it “a permanent lock-in; a single point of failure”. The junior health minister, Zubir Ahmed, said Palantir does not own the data, the products or the intellectual property. The two accounts of the Palantir NHS contract have not been reconciled in public.
4. Sovereignty
The science committee warned about the UK’s growing dependence on a handful of US technology suppliers. Wrigley, one of its members, told AFP that Trump could decide that Palantir’s services to the UK should be “switched off” if “he doesn’t like what Andy Burnham says, or they differ on Ukraine or something”. He wants a replacement “within the control of a UK, preferably UK-owned firm”.
5. Value for money
The quietest critics may matter most. The Chief Data and Analytics Officers Network, which represents senior NHS data staff, wrote that the platform “has been unable to demonstrate the level of evidence, confidence and realised value that should be expected following sustained investment and extensive policy support”, and urged the government to “consider the break clause”. Wrigley told MPs that about 200 trusts had announced plans to join, that only about half were live, and that only a quarter of user organisations reported benefits.
The Case for Keeping the Palantir NHS Contract
The Palantir NHS contract has defenders, and their argument rests on results and on the cost of change.
What Palantir says it delivers
Palantir, which did not respond to AFP, says the platform has helped enable 110,000 additional operations while cutting waiting lists. In its statement to the Guardian, the figure was 117,000 additional operations, plus a 14.3% cut in discharge delays for long-stay patients. Around two-thirds of NHS hospitals have adopted the system. The company has also claimed a 6.8% increase in cancer diagnoses.
What the government says
“The benefits of the FDP service are clear, with thousands more patients benefitting every month, including through the reduction in the number of unnecessary days spent in hospital after treatment,” a Department of Health spokesperson told AFP. In April Ahmed said he was “no fan” of Palantir’s politics, but that the platform’s principles were critical to the NHS’s future. “My north star is always patient safety and quality, and of course value for money,” he said, adding that if other providers could “do the job better”, that “needs to be looked at”.
The cost of switching
Even critics accept that leaving the Palantir NHS contract would not be free. The platform is embedded in many acute trusts through custom connectors, and the £24.9 million exit contract shows that a transition has already been planned for. NHS England has also paid Imperial College Projects about £700,000 to evaluate the platform, but that review runs from March 2026 to 2029, so its full findings will arrive after the break point.
| Claim | Who makes it | What is still missing |
|---|---|---|
| 110,000 or 117,000 extra operations | Palantir | A published method and baseline |
| 14.3% fewer discharge delays | Palantir | Which trusts, and compared with what |
| Two-thirds of hospitals have adopted it | Supporters, via AFP | How many use it daily |
| Only a quarter report benefits | Martin Wrigley MP | The underlying survey |
| Data never leaves NHS control | NHS England, Palantir | An answer to the committee’s statutory-basis question |
What the Break Clause in the Palantir NHS Contract Allows
The break point in the Palantir NHS contract gives ministers four realistic choices, and each has a price.
Extend
Triggering the first two-year extension keeps the platform running and avoids disruption. It also hands the strongest argument to critics, who would read it as proof that the NHS cannot leave.
Break and re-tender
Ending the Palantir NHS contract at the first term and running a new competition would answer the sovereignty case. The original procurement drew bids from the British company Quantexa with IBM, and from Oracle Cerner. A new tender would take time, and trusts would need support through the switch.
Build in-house
NHS Greater Manchester has spent a decade building its own data platform that does some of the same work. “What we’ve built to meet the system needs is better” for local patients, its chief data officer, Matt Hennessey, told AFP, adding that other regions could do the same. The science committee also suggested “an in-house replacement” or an alternative from “UK-owned and UK-based providers”.
Renegotiate
A middle path would keep the platform but change the terms: transfer ownership of connecting code, tighten audit rights, and publish performance data. That would test whether the lock-in fears are about the contract or about the company.
The exit plan deadline
Campaign groups say 30 September 2026 was the contractual deadline for Palantir to give NHS England an exit plan, the document that sets out how the service would be handed over if the Palantir NHS contract ends. Neither side has said in public whether it arrived. Whatever ministers decide, that plan is what makes a break in the Palantir NHS contract credible rather than theoretical, because it shows what a hand-over would involve and how long it would take.
Palantir's Wider Footprint in Britain
The Palantir NHS contract is the most visible part of a larger presence. AFP reports that the UK is Palantir’s second-largest market, making up 10% of the company’s revenue in 2025.
Defence, police and finance
Palantir signed a £240 million defence deal in 2025, and Technology Magazine put its UK public-sector contracts at about £600 million in total. It works with 11 police forces. In March it won a contract to analyse Financial Conduct Authority data. In May the London mayor, Sadiq Khan, blocked a £50 million Metropolitan Police contract, citing procurement concerns, and Palantir has taken legal action. Britain’s electricity grid operator has also given Palantir a £21 million direct award without competition, The Next Web reports.
A familiar face
In September Tom Watson, the former Labour deputy leader, joined Palantir as a senior vice president. “We have challenges. Some criticism is propaganda. Some raises legitimate questions about large technology companies and sovereign control. Both require answers,” he said. The Green MP Sian Berry called the move a “corrosive revolving door”.
What Europe is doing
France has moved its intelligence agencies away from Palantir this year, replacing it with software from the French company ChapsVision, and German media report that Berlin is testing the same French technology. For our earlier coverage of Palantir’s government work, see how Palantir brings secure AI to US agencies with Nvidia Nemotron, and how its forward-deployed engineering model embeds staff inside customers.
Public pressure in numbers (people, from the figures cited above)
What the Palantir NHS Contract Means for Patients
For most patients nothing changes this week. Objecting does not affect anyone’s right to treatment, and the platform is mainly used to manage hospital operations such as waiting lists, theatre schedules and discharges.
The 44,000 objections
The 38 Degrees campaign used article 21 of the UK GDPR, the right to object. Under it an organisation must stop processing a person’s data unless it can show compelling legitimate grounds to continue. The objectors also asked NHS England to pause processing while it considers the requests. NHS England told the Guardian it would respond under data protection law. “The scale of this public backlash should be a huge wake-up call for the government,” said Veronica Hawking, campaigns director at 38 Degrees.
Opt-outs and trust
Separately, the national data opt-out lets patients in England stop their confidential information being used for research and planning. A health minister told MPs in September that distrust of Palantir appeared to be behind a rise in opt-outs, and Medact says more than 85,000 patients have complained to their hospitals. Every opt-out makes NHS data less complete, which is the cost the trust argument warns about.
Lessons From the Palantir NHS Contract for UK Buyers
Few organisations will sign a deal the size of the Palantir NHS contract, but the questions in this row apply to any business buying a platform that sits under its operations.
Own what you pay for
Check who owns custom code, connectors and configuration. If the answer is the supplier, price in the cost of rebuilding them when you leave. Wrigley’s lock-in complaint is a contract-drafting problem first.
Write the exit before you sign
Ask for an exit plan, a data export format and a transition period at the start. The FDP already has an exit contract. Most smaller buyers have nothing similar.
Plan for the supplier’s reputation
A supplier’s other customers can become your problem. Build a review point into long contracts so you can act if trust changes, and keep a record of the data protection basis for every use of personal data. Our guidance on data protection covers the UK GDPR duties that sit with you, not your supplier.
Measure benefits from day one
The Palantir NHS contract debate is hard to settle because the evidence is partial. Agree how benefits will be measured, publish the baseline, and you will not be relying on the supplier’s figures when renewal comes.
Palantir NHS Contract FAQ
What is the Palantir NHS contract?
It is a contract, awarded in November 2023, for a Palantir-led group to run the NHS Federated Data Platform, which links data across hospitals to manage waiting lists and patient flow. It is worth up to £330 million over seven years.
When can the government end the Palantir NHS contract?
At the end of its first three-year term, in February or March 2027, by not triggering the first extension. Ministers are expected to decide by December 2026.
Does Palantir own NHS patient data?
The NHS and Palantir say no. The data stays in Britain, the NHS controls it, and it is not used for commercial purposes or AI training. A Commons committee has asked the government to explain reports of wider access.
Why do doctors oppose the deal?
The British Medical Association opposes the Palantir NHS contract on grounds of patient trust, data security and NHS independence, and points to Palantir’s work for US immigration enforcement. It has advised doctors not to use the platform.
Can I stop my data going into the platform?
You can register a national data opt-out for research and planning, and campaigners have used the UK GDPR right to object. Neither affects your care. Check NHS guidance for how each applies.
Who decides what happens next?
The Department of Health and Social Care decides on the Palantir NHS contract, with the prime minister, Andy Burnham, who has not yet commented publicly.
References and Further Reading
UK fears grow over AI giant Palantir’s health service deal (AFP via Tech Xplore)
44,000 object to Palantir’s NHS data platform (The Next Web)
Palantir’s NHS future in doubt as ministers eye contract break (The Register)
MPs tell government to end £330m NHS contract with Palantir (Novara Media)
What the Federated Data Platform break clause means for suppliers (Stotles)
Pressure grows to end Palantir’s £330m NHS data contract (Resultsense)
Tom Watson joins Palantir as its NHS contract heads for a break clause (The Next Web)
UK government urged to cut Palantir ties as public backlash grows (Technology Magazine)
Coalition urges NHS organisations to refuse Palantir’s software (BMJ Future Health)
More AI coverage: explore Progressive Robot's AI Models, Tools & Releases hub — hands-on reviews, setup guides and benchmarks in one place.
